Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel

NCT01668459 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Transitional Cell Carcinoma

Interventions

DRUG: Cabazitaxel
OTHER: Best Supportive Care

Sponsor

Dr Anjali Zarkar

Collaborators

[object Object]